feed,title,long_url,short_url
Benzinga,"Despite Early Approval Of Omidubicel, Analyst Says Longer-Term Financial Overhang Remains For Gamida Cell",https://benzinga.com/analyst-ratings/analyst-color/23/04/31921578/despite-early-approval-of-omidubicel-analyst-says-longer-term-financial-overhang-re,https://da.gd/BCaJDO
